Clinical Trial Update: A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy [Phase 1]

View source ↗

Summary

This clinical trial update indicates that a Phase 1 study of a new insulin for Type 2 diabetes patients on insulin injections has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Unspecified insulin (new type)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: WITHDRAWN